InvestorsHub Logo
Followers 78
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Re: None

Sunday, 09/03/2017 6:28:25 PM

Sunday, September 03, 2017 6:28:25 PM

Post# of 3881
The SP is going down - the trials are going on but seems the issue is with key trial completion dates.

I checked clinicaltrials.gov side and saw few trials updated at the end of Aug. 2 trials are related IBS are completed but remaining trial completion is in much future so there are no major milestones to bring price above $10

Interventions- Conditions-Last Updated-Primary Completion Dt

Drug: RHB-105 - Helicobacter Pylori Infection -6/27/2017-Jul'18

Drug: RHB-104- Crohn Disease-8/29/2017-Jun'19

Drug: ABC294640- Carcinoma, Hepatocellular-2/24/2017-Jan'21

Drug: ABC294640- Multiple Myeloma-2/21/2017-Dec'19

Drug: ABC294640- Diffuse Large B Cell Lymphoma -4/25/2017-Jun'19

Drug: RHB-104 - Crohn's Disease-8/29/2017-Sept'17

All trials are recruiting.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDHL News